Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
Journal Title: Journal of Urological Surgery - Year 2019, Vol 6, Issue 2
Abstract
Oral pharmacotherapy constitutes second-line treatment for overactive bladder (OAB) after lifestyle modifications, bladder retraining, and pelvic floor muscle exercises. Antimuscarinics have an established role in the treatment of OAB. However, antimuscarinics are known to have low persistence rates in clinical practice. Mirabegron is an oral β3-adrenoreceptor agonist which has emerged as an alternative to antimuscarinics for managing OAB. Overall, mirabegron has similar clinical efficacy to antimuscarinics and is superior to placebo. Mirabegron has been generally well tolerated in both interventional and non-interventional studies. Persistence has been shown to be higher with mirabegron than with antimuscarinics in realworld studies. Increased blood pressure is associated with mirabegron and therefore its use is contraindicated in patients with severe uncontrolled hypertension. However, a low rate of treatment cessation due to cardiovascular issues has been noted in clinical trials. Mirabegron’s utility in the elderly patient population has been well supported with promising efficacy and safety outcomes. New data from a prospective placebo-controlled randomized trial in older OAB patients is expected to be published soon. Mirabegron does not interfere with detrusor contractions during the emptying phase of the micturition cycle and hence lacks any significant effect on post-void residual volume. Mirabegron can be combined with antimuscarinics to synergize clinical effectiveness. Overall, mirabegron represents a well-tolerated and effective medical treatment option for OAB. Mirabegron could be used as an alternative to antimuscarinics, especially in patients who do not improve with antimuscarinics and/or experience bothersome side effects for whom anticholinergic load may be a relevant consideration.
Authors and Affiliations
Ömer Acar, Mustafa Levent Erton, Tufan Tarcan
Keywords
Related Articles
- EP ID EP48971
- DOI 10.4274/jus.galenos.2019.2533
- Views 378
- Downloads 0
Gigantic Calculi in Continent Urinary Diversion
Continent urinary reservoirs are safe and accepted modes of urinary diversion in selected patients. However, they are associated with long-term complications such as recurrent pyelonephritis, metabolic acidosis, urolithi...
Paratesticular Solitary Fibrous Pseudotumor and a Brief Literature Review
A 19-year-old male patient was admitted to our clinic with a left-sided scrotal painless mass. Ultrasonography of the scrotum revealed a paratesticular mass arising from the left testicular sac. Surgical excision of the...
The Efficacy of N-acetylcysteine Against Renal Oxidative Stress After Extracorporeal Shock Wave Treatment: An Experimental Rat Model
Objective: To evaluate effects of renal extracorporeal shock wave lithotripsy (SWL) on plasma Oxidative Stress index (OSI) and to observe histopathological alterations in an experimental model. Secondly, protective role...
The Clinical and Uropathological Aspects of Neuroendocrine Tumours of the Bladder: A Review
Neuroendocrine tumours of the bladder are less common than other histologic types (e.g., urothelial carcinoma, squamous cell carcinoma, adenocarcinoma), constituting 1% of malignant bladder cancers. Based on the “2016 Wo...
The Largest Cystic Nephroma Treated by Laparoscopic Nephronsparing Surgery: A Case Report and Review of the Literature
Cystic nephroma is a rare benign tumour of the kidney. The symptoms are often non-specific and the diagnosis of the disease is usually made incidentally. Definitive diagnosis can be possible with histopathological evalua...